Forward BIOLABS will be accepting applications for Round 2 of its Innovation to Commercialization Pipeline (ICP) Program between May 26 and June 19, the company announced recently.

ICP will continue providing targeted support to young biohealth companies across Wisconsin as they advance technologies toward commercialization and long-term growth.

According to a release, round 2 ICP awardees will be selected through a competitive review process led by an experienced committee of industry leaders, investors and commercialization experts. Awardees will be announced in August.

As previously reported, the program is in partnership with BioForward Wisconsin.

Applications can be submitted here.